Cannabis and hemp stocks have surged in the weeks following President Joe Biden’s electoral victory, and the industry could see some big days ahead under the Biden Administration. Biden vowed ahead of election day to decriminalize cannabis, and there is an expectation in the industry that this will result in a stronger, more unified regulatory framework. For the hemp-derived CBD market, this could mean opportunities for expansion into new markets, as well as new distribution opportunities for CBD health and wellness products to be sold in a wider range of stores. This could be the largest regulatory growth opportunity for companies like HempFusion Wellness Inc. (TSX: CBD.U) (OTCPK: CBDHF), Tilray Inc (NASDAQ: TLRY), Canopy Growth Corp (NASDAQ: CGC) (TSX: WEED), Cronos Group Inc (NASDAQ: CRON) (TSX: CRON), and OrganiGram Holdings Inc (TSX: OGI) (NASDAQ: OGI) since the first US states opened up to medicinal CBD and cannabis products.
HempFusion’s Regulatory Standards Open Doors
Denver-based health and wellness company HempFusion Wellness Inc. (TSX:CBD.U) is set up to flourish in a broader and more unified US CBD regulatory regime. The company has endeavored to build itself up to be the gold standard for health and safety regulatory compliance in the CBD market, allowing it the opportunity to move into newly opened markets and retailers that had not previously carried CBD products without the need for significant operational changes.
HempFusion’s high standards have already opened doors for the company that may remain closed to other CBD companies. HempFusion has developed a regulatory portfolio and the company’s products are available at a combined 4,000+ retail sales locations throughout the United States, including major retailers like Whole Foods. HempFusion is also working on developing trust among healthcare professionals, which may provide the company with the opportunity to sell directly to healthcare practitioner networks through two specialized medical CBD brands.
A new, more open regulatory landscape in the US will likely add to these opportunities, and HempFusion could be among the first CBD companies to benefit.
HempFusion specializes in broad spectrum CBD products derived from hemp, whereas most other companies derive their products from hybrid cannabis plants. The company uses an exclusive hemp-derived CBD extract fused together with other scientifically validated ingredients that support targeted areas, including skincare, nutrition, stress, sleep, and more. The company’s Topical products are focused on the Over-The-Counter (OTC) drug listed market, which allows HempFusion to target the formulas towards very specific applications with legally permissible health claims, such as pain. These formulas include a skin nourishing proprietary blend that includes hemp-derived CBD and so much more.
HempFusion’s wholly-owned subsidiary Probulin Probiotics LLC is a successful probiotics company and is pivotal in deploying the company’s ‘Trojan Horse’ strategy as a gateway to gain access to new markets as US regulatory development accelerates over the next four years. HempFusion’s Probulin subsidiary is a market-leading probiotics brand that does not include CBD products. HempFusion’s Probulin, already successful and one of the fastest growing probiotic companies in the Natural products market, according to SPIN data, may allow the company to enter markets and retailers before they open up to CBD. As regulations develop, HempFusion is able to use those established relationships and trust to make sure its products are among the first stocked.
The Nation’s Largest CBD Producers See Renewed Opportunity
Around the industry, hemp-CBD and cannabis producers are looking at Biden’s victory as a source of new optimism for cannabis companies. Tilray Inc (NASDAQ:TLRY) has been one of the cannabis industry’s top performers so far in 2021 since the cannabis giant merged with Aphria to become the largest company in the industry.
Canopy Growth Corp (NASDAQ:CGC) (TSX:WEED) also celebrated the results of the election. The Canadian company has been looking south to the US market for some time now, and the regulatory headwind that cannabis companies expect from the Biden administration will likely remove barriers to US expansion.
That regulatory headwind would likely also be a boon to Cronos Group Inc (NASDAQ:CRON) (TSX:CRON). Cronos announced in 2019 that the company would be expanding into the US market through the acquisition of four hemp-derived CBD subsidiaries from US-based Redwood Holding Group.
OrganiGram Holdings Inc (TSX:OGI) (NASDAQ:OGI) released its first quarter 2021 results on January 12, recording extremely positive results. For adult-use recreational products, the company saw gross and net revenue growth of 42 percent and 30 percent, respectively, reaching $22.5 million and $16.8 million.
The next four years could be big days for the United States hemp-CBD and cannabis markets, and companies are looking to take advantage of the growth opportunity. For HempFusion Wellness, this means using the company’s uncompromising approach to compliance to gain access to new markets early as they open up.
Click here to find out more about HempFusion Wellness.
Disclaimer: Microsmallcap.com (MSC) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with MSC or any company mentioned herein. The commentary, views and opinions expressed in this release by MSC are solely those of MSC and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable MSC and FNM for any investment decisions by their readers or subscribers. MSC and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author (MSC), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (MSC) has not independently verified or otherwise investigated all such information. None of the Author, MSC, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated twenty five hundred dollars by MSC, a non-affiliated third party to distribute this release on behalf of Bragg Gaming Group
FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MSC and FNM undertake no obligation to update such statements.